These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23098579)

  • 21. Simultaneous integrated boost for adjuvant treatment of breast cancer--intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trial.
    Askoxylakis V; Jensen AD; Häfner MF; Fetzner L; Sterzing F; Heil J; Sohn C; Hüsing J; Tiefenbacher U; Wenz F; Debus J; Hof H
    BMC Cancer; 2011 Jun; 11():249. PubMed ID: 21676232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life: Impact of surgery and treatment modality in breast cancer.
    Enien MA; Ibrahim N; Makar W; Darwish D; Gaber M
    J Cancer Res Ther; 2018; 14(5):957-963. PubMed ID: 30197331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score.
    Heymann S; Dipasquale G; Nguyen NP; San M; Gorobets O; Leduc N; Verellen D; Storme G; Van Parijs H; De Ridder M; Vinh-Hung V
    Technol Cancer Res Treat; 2020; 19():1533033820947759. PubMed ID: 32940569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study.
    Yucel B; Akkaş EA; Okur Y; Eren AA; Eren MF; Karapinar H; Babacan NA; Kiliçkap S
    Support Care Cancer; 2014 Sep; 22(9):2479-87. PubMed ID: 24728584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life of breast cancer patients after accelerated partial breast irradiation using intraoperative or external beam radiotherapy technique.
    Jacobs DHM; Horeweg N; Straver M; Roeloffzen EMA; Speijer G; Merkus J; van der Sijp J; Mast ME; Fisscher U; Petoukhova AL; Zwanenburg AG; Marijnen CAM; Koper PCM
    Breast; 2019 Aug; 46():32-39. PubMed ID: 31075670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or Tomotherapy for breast cancer.
    Lee HH; Chen CH; Luo KH; Chuang HY; Huang CJ; Cheng YK; Chen F; Kuo SH; Huang MY
    Sci Rep; 2020 Mar; 10(1):4342. PubMed ID: 32152428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens.
    Jacobs DHM; Charaghvandi RK; Horeweg N; Maduro JH; Speijer G; Roeloffzen EMA; Mast M; Bantema-Joppe E; Petoukhova AL; van den Bongard DHJG; Koper P; Crijns APG; Marijnen CAM; Verkooijen HM
    Breast Cancer Res Treat; 2021 Sep; 189(2):387-398. PubMed ID: 34216316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
    Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients' perceptions of health-related quality of life during and after adjuvant radiotherapy for T1N0M0 breast cancer.
    Sundaresan P; Sullivan L; Pendlebury S; Kirby A; Rodger A; Joseph D; Campbell I; Dhillon HM; Stockler MR
    Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):9-15. PubMed ID: 25267304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
    Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
    Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial.
    Prescott RJ; Kunkler IH; Williams LJ; King CC; Jack W; van der Pol M; Goh TT; Lindley R; Cairns J
    Health Technol Assess; 2007 Aug; 11(31):1-149, iii-iv. PubMed ID: 17669280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated radiotherapy in patients over sixty years old after mastectomy: Acute and one-year physician-assessed toxicity and health-related quality of life.
    Vakaet V; Van Hulle H; Quataert V; Deseyne P; Schoepen M; Paelinck L; Post G; Van Greveling A; Speleers B; Mareel M; De Neve W; Monten C; Veldeman L
    Breast Dis; 2022; 41(1):261-266. PubMed ID: 35599462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post treatment quality of life among Sri Lankan women with breast cancer.
    Jayasinghe R; Fernando A; Jayarajah U; Seneviratne S
    BMC Cancer; 2021 Mar; 21(1):305. PubMed ID: 33757446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
    Schwartzberg L; McIntyre K; Wilks S; Puhalla S; O'Shaughnessy J; Berrak E; He Y; Vahdat L
    BMC Cancer; 2019 Jun; 19(1):578. PubMed ID: 31195996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
    Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
    J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.